FI912888L - 2-(aminoalkyl)-5-(arylalkyl)-1,3 -dioxanderivat, deras framstaellning och terapeutiska tillaempning. - Google Patents

2-(aminoalkyl)-5-(arylalkyl)-1,3 -dioxanderivat, deras framstaellning och terapeutiska tillaempning. Download PDF

Info

Publication number
FI912888L
FI912888L FI912888A FI912888A FI912888L FI 912888 L FI912888 L FI 912888L FI 912888 A FI912888 A FI 912888A FI 912888 A FI912888 A FI 912888A FI 912888 L FI912888 L FI 912888L
Authority
FI
Finland
Prior art keywords
dioxanderivat
tillaempning
aminoalkyl
arylalkyl
therapeutic
Prior art date
Application number
FI912888A
Other languages
English (en)
Finnish (fi)
Other versions
FI912888A0 (fi
FI912888A7 (fi
Inventor
Bernard Raizon
Yannick Evanno
Odette Legalloudec
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9007483A external-priority patent/FR2663330B1/fr
Priority claimed from FR9104578A external-priority patent/FR2675143B3/fr
Application filed by Synthelabo filed Critical Synthelabo
Publication of FI912888A0 publication Critical patent/FI912888A0/fi
Publication of FI912888A7 publication Critical patent/FI912888A7/fi
Publication of FI912888L publication Critical patent/FI912888L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Medicinal Preparation (AREA)
FI912888A 1990-06-15 1991-06-14 2-(aminoalkyl)-5-(arylalkyl)-1,3 -dioxanderivat, deras framstaellning och terapeutiska tillaempning. FI912888L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9007483A FR2663330B1 (fr) 1990-06-15 1990-06-15 0derives de 2-(aminoalkyl)-5-(arylalkyl)-1,3-dioxanes, leur preparation et leur application en therapeutique.
FR9104578A FR2675143B3 (fr) 1991-04-15 1991-04-15 Derives de 2-(aminoalkyl)-5-naphtyl-1,3-dioxanes, leur preparation et leur application en therapeutique.

Publications (3)

Publication Number Publication Date
FI912888A0 FI912888A0 (fi) 1991-06-14
FI912888A7 FI912888A7 (fi) 1991-12-16
FI912888L true FI912888L (fi) 1991-12-16

Family

ID=26228078

Family Applications (1)

Application Number Title Priority Date Filing Date
FI912888A FI912888L (fi) 1990-06-15 1991-06-14 2-(aminoalkyl)-5-(arylalkyl)-1,3 -dioxanderivat, deras framstaellning och terapeutiska tillaempning.

Country Status (20)

Country Link
US (1) US5192797A (cs)
EP (1) EP0461958B1 (cs)
JP (1) JPH0813808B2 (cs)
KR (1) KR920000744A (cs)
AT (1) ATE111460T1 (cs)
AU (1) AU643290B2 (cs)
CA (1) CA2044699A1 (cs)
CZ (1) CZ280084B6 (cs)
DE (1) DE69103968T2 (cs)
DK (1) DK0461958T3 (cs)
ES (1) ES2064057T3 (cs)
FI (1) FI912888L (cs)
HU (1) HU208432B (cs)
IE (1) IE65067B1 (cs)
IL (1) IL98454A (cs)
NO (1) NO177995C (cs)
NZ (1) NZ238557A (cs)
PL (1) PL164840B1 (cs)
PT (1) PT97991B (cs)
SK (1) SK278142B6 (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2714058B1 (fr) * 1993-12-22 1996-01-19 Synthelabo Dérivés de 1,3-dioxane trisubstitués, leur préparation et leur application en thérapeutique.
FR2714055B1 (fr) * 1993-12-22 1996-01-19 Synthelabo Dérivés de 5-(arylalkyl)-1,3-dioxane substitués en position 2, leur préparation et leur utilisation en thérapeutique.
FR2714056B1 (fr) * 1993-12-22 1996-01-19 Synthelabo Dérivés de 2-(aminoalkyl)-5-(arylalkyl)-1,3-dioxane, leur préparation et leur application en thérapeutique.
FR2720939B1 (fr) * 1994-06-08 1996-07-12 Synthelabo Utilisation de dérivés de N-[[5-(naphtalén-1-yl)-1,3-dioxan-2-yl]alkyl] acétamide pour la préparation de médicaments utiles dans le traitement des désordres neurodégénératifs.
FR2742152B1 (fr) * 1995-12-06 1998-01-16 Synthelabo Derives de 5-naphtalen-1-yl-1,3-dioxanes, leur preparation et leur application en therapeutique
FR2764287B1 (fr) * 1997-06-05 1999-07-16 Synthelabo Derives de 5-naphtalen-1-yl-1,3-dioxanes, leur preparation et leur application en therapeutique
PL337234A1 (en) * 1997-06-05 2000-08-14 Sanofi Synthelabo Derivatives of 5-naphtalen-1-yl-1,3-dioxane, their production and therapeutic application
FR2843964B1 (fr) * 2002-08-29 2004-10-01 Sanofi Synthelabo Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique
GB2397067B (en) * 2002-12-23 2005-05-11 Destiny Pharma Ltd Porphin & azaporphin derivatives with at least one cationic-nitrogen-containing meso-substituent for use in photodynamic therapy & in vitro sterilisation
EP1604654A1 (en) * 2004-05-18 2005-12-14 Schwarz Pharma Ag Novel use of peptide compounds for treating dyskinesia
GB2415372A (en) 2004-06-23 2005-12-28 Destiny Pharma Ltd Non photodynamical or sonodynamical antimicrobial use of porphyrins and azaporphyrins containing at least one cationic-nitrogen-containing substituent
EP2310372B1 (en) 2008-07-09 2012-05-23 Sanofi Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
WO2016115504A1 (en) 2015-01-15 2016-07-21 Allaysis, Llc Intravenous baclofen formulations and treatment methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1554878A (cs) * 1967-12-12 1969-01-24
US4116670A (en) * 1977-04-04 1978-09-26 Velsicol Chemical Company Dioxane substituted amides
US4097491A (en) * 1977-06-10 1978-06-27 Velsicol Chemical Corporation N-Dialkoxyalkyl-N-dioxanalkylene-α-haloalkanamides

Also Published As

Publication number Publication date
NZ238557A (en) 1992-04-28
IE912045A1 (en) 1991-12-18
NO912298D0 (no) 1991-06-14
PL164840B1 (pl) 1994-10-31
IL98454A0 (en) 1992-07-15
NO177995B (no) 1995-09-25
FI912888A0 (fi) 1991-06-14
US5192797A (en) 1993-03-09
AU7843391A (en) 1991-12-19
FI912888A7 (fi) 1991-12-16
CS183791A3 (en) 1992-01-15
KR920000744A (ko) 1992-01-29
PT97991B (pt) 1998-11-30
IE65067B1 (en) 1995-10-04
ES2064057T3 (es) 1995-01-16
DK0461958T3 (da) 1995-02-20
EP0461958B1 (fr) 1994-09-14
DE69103968D1 (de) 1994-10-20
NO912298L (no) 1991-12-16
IL98454A (en) 1996-07-23
CZ280084B6 (cs) 1995-10-18
ATE111460T1 (de) 1994-09-15
JPH04230277A (ja) 1992-08-19
PT97991A (pt) 1992-03-31
NO177995C (no) 1996-01-03
JPH0813808B2 (ja) 1996-02-14
SK278142B6 (en) 1996-02-07
AU643290B2 (en) 1993-11-11
HUT59124A (en) 1992-04-28
PL290676A1 (en) 1991-12-16
HU208432B (en) 1993-10-28
HU911992D0 (en) 1991-12-30
EP0461958A1 (fr) 1991-12-18
DE69103968T2 (de) 1995-03-23
CA2044699A1 (en) 1991-12-16

Similar Documents

Publication Publication Date Title
FI923526A0 (fi) Braennsystem foer braensle, foerfarande och dysorgan foer detsamma.
FI914961A7 (fi) Peptidfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutisk blandning.
FI911211A0 (fi) Romboedriskt kalciumkarbonat och accelererat, termiskt aoldringsfoerfarande foer framstaellning daerav.
FI912379A0 (fi) Eldfast, vattenbestaendigt och syrafast bindemedel.
FI923375L (fi) Anordning och foerfarande foer iontoforetisk transfusion.
FI913503A7 (fi) Bensimidazoler, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
FI915488L (fi) Kondenserade heterocykliska foereningar, deras framstaellning och anvaendning.
FI911584L (fi) Substituerade azoler, foerfarande foer deras framstaellning, dessa innehaollande aemnen och deras anvaendning.
FI923548L (fi) Skumbildande komposition foer farmaceutisk anvaendning, anvaendning daerav och behandlingsmetod.
FI910311A0 (fi) Kalorifattiga, icke-kariogena aetbara kompositioner och foerfarande foer deras framstaellning.
FI912888L (fi) 2-(aminoalkyl)-5-(arylalkyl)-1,3 -dioxanderivat, deras framstaellning och terapeutiska tillaempning.
FI921925A7 (fi) Kemiluminescerande 3-(substituerad adamant-2-yliden)-1,2-dioxetaner.
FI913983L (fi) Svampmotverkande triazolderivat, deras framstaellning och anvaendningar.
FI910440A0 (fi) Alkenylgrupper innehaollande siloxankopolymerer, deras framstaellning och anvaendning.
FI913067L (fi) Bisfosfonsyraderivat, deras framstaellning och anvaendning.
FI922979A0 (fi) 2-piperidin-l-yl)etanolderivat, deras framstaellning och terapeutiska anvaendning.
FI914182A0 (fi) Maetningsfoerfarande foer magnetfaelt, maetningsapparat foer magnetfaelt, visningsfoerfarande foer magnetfaelt och visningsapparat foer magnetfaelt.
FI910325L (fi) Differentiering av mikroorganismer associerade med parodontala sjukdomar, och daervid anvaendbar artikel och testfoerpackning.
FI923492L (fi) Indolderivat, deras framstaellning och anvaendning.
FI912223A0 (fi) Katalytkompositioner och polymeriseringsfoerfarande, hexakisfosfiner och hexahalogenfoereningar.
FI914525L (fi) Foerening, anvaendning och framstaellning.
FI914114L (fi) Jodinerade, icke-joniserade foereningar, foerfarande foer deras framstaellning och dessa innehaollande kontrastmedel.
FI913654L (fi) 2-(9-fluorenonyl)-karbapenem.
FI913655A0 (fi) 2-(9-fluorenonyl)-karbapenem antibakteriella foereningar.
FI914642L (fi) Inklusionskomplex med silybin, deras framstaellning och dessa innehaollande farmaceutiska blandningar.

Legal Events

Date Code Title Description
FA Application withdrawn [patent]